AJP - Lung Cellular and Molecular Physiology, Vol 273, Issue 5 1048-L1057, Copyright © 1997 by American Physiological Society

ARTICLES

Glucocorticoid regulation of surfactant components in immature lambs

P. L. Ballard, Y. Ning, D. Polk, M. Ikegami and A. H. Jobe
Department of Pediatrics, University of Pennsylvania School of Medicine, Children's Hospital of Philadelphia 19104, USA.

To assess effects of dose and duration of glucocorticoid exposure on maturation of the fetal lung, we administered single or multiple doses of betamethasone (0.5 mg/kg im) to pregnant sheep for 2 or 21 days before preterm delivery at 125 days of gestation. Lung function (compliance, lung volume at 40 cmH2O pressure, and ventilatory efficiency index) was increased after two to four weekly doses of glucocorticoid (2.5- to 4-fold increase) and after 48 h of exposure (1.4- to 2.3-fold). Total protein of lavage fluid decreased similarly with three doses, four doses, and 48 h of treatment. In lambs with long-term exposure to betamethasone, there was a similar, dose-dependent increase in concentrations of saturated phosphatidylcholine and surfactant proteins A (SP-A) and B (SP-B) (maximal 2- to 3-fold in tissue and 10- to 15-fold in lavage fluid). Levels of SP-A and SP-B were closely correlated in lavage fluid. In animals treated for 48 h, only tissue SP-B was increased (2.7-fold). We conclude that 48 h of glucocorticoid treatment improves lung function in the premature lamb without a detectable increase in lavage surfactant components and that longer exposure to antenatal glucocorticoid increases surfactant lipid and proteins in a coordinated fashion. The enhanced response with repetitive dosing indicates that the process of glucocorticoid-induced lung maturation is either reversible and/or gestational age dependent.

This article has been cited by other articles:

				S. J. Flecknoe, R. E. Boland, M. J. Wallace, R. Harding, and S. B. Hooper Regulation of alveolar epithelial cell phenotypes in fetal sheep: roles of cortisol and lung expansion Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1207 - L1214. [Abstract] [Full Text] [PDF]

				A. Hamvas, L. M. Nogee, F. V. White, P. Schuler, B. P. Hackett, C. B. Huddleston, E. N. Mendeloff, F.-F. Hsu, S. E. Wert, L. W. Gonzales, et al. Progressive Lung Disease and Surfactant Dysfunction with a Deletion in Surfactant Protein C Gene Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 771 - 776. [Abstract] [Full Text] [PDF]

				M. Ikegami, R. Dhami, and E. H. Schuchman Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L518 - L525. [Abstract] [Full Text] [PDF]

				L. W. Gonzales, S. H. Guttentag, K. C. Wade, A. D. Postle, and P. L. Ballard Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L940 - L951. [Abstract] [Full Text] [PDF]

				L. C. Sullivan, S. Orgeig, and C. B. Daniels Control of the development of the pulmonary surfactant system in the saltwater crocodile, Crocodylus porosus Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1164 - R1176. [Abstract] [Full Text] [PDF]

				A. H. JOBE and E. BANCALARI Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1723 - 1729. [Full Text] [PDF]

				K. E. WILLET, A. H. JOBE, M. IKEGAMI, J. KOVAR, and P. D. SLY Lung Morphometry after Repetitive Antenatal Glucocorticoid Treatment in Preterm Sheep Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1437 - 1443. [Abstract] [Full Text]

				J. E. H. BUNT, V. P. CARNIELLI, J. L. DARCOS WATTIMENA, W. C. HOP, P. J. J. SAUER, and L. J. I. ZIMMERMANN The Effect in Premature Infants of Prenatal Corticosteroids on Endogenous Surfactant Synthesis as Measured with Stable Isotopes Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 844 - 849. [Abstract] [Full Text]

				P. L. Ballard Scientific Rationale for the Use of Antenatal Glucocorticoids to Promote Fetal Development NeoReviews, May 1, 2000; 1(5): e83 - 90. [Full Text]

				R. C. Tan, M. Ikegami, A. H. Jobe, L. Y. Yao, F. Possmayer, and P. L. Ballard Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1142 - L1148. [Abstract] [Full Text] [PDF]

				J. E. H. BUNT, V. P. CARNIELLI, S. R. SEIDNER, M. IKEGAMI, J. L. DARCOS WATTIMENA, P. J. J. SAUER, A. H. JOBE, and L. J. I. ZIMMERMANN Metabolism of Endogenous Surfactant in Premature Baboons and Effect of Prenatal Corticosteroids Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1481 - 1485. [Abstract] [Full Text]

				R. Gagnon, J. Langridge, K. Inchley, J. Murotsuki, and F. Possmayer Changes in surfactant-associated protein mRNA profile in growth-restricted fetal sheep Am J Physiol Lung Cell Mol Physiol, March 1, 1999; 276(3): L459 - L465. [Abstract] [Full Text] [PDF]

				A. H. JOBE and M. IKEGAMI Surfactant Homeostasis in Corticotropin-releasing Hormone Deficiency in Adult Mice Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 995 - 997. [Abstract] [Full Text] [PDF]

				F. J. Walther, A. H. Jobe, and M. Ikegami Repetitive prenatal glucocorticoid therapy reduces oxidative stress in the lungs of preterm lambs J Appl Physiol, July 1, 1998; 85(1): 273 - 278. [Abstract] [Full Text] [PDF]